BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12525871)

  • 1. Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone.
    Valle MT; Porta C; Megiovanni AM; Libener R; Mele L; Gaudino G; Strizzi L; Guida R; Toma S; Mutti L
    Int J Mol Med; 2003 Feb; 11(2):161-7. PubMed ID: 12525871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma.
    Cordier Kellerman L; Valeyrie L; Fernandez N; Opolon P; Sabourin JC; Maubec E; Le Roy P; Kane A; Legrand A; Abina MA; Descamps V; Haddada H
    Cancer Gene Ther; 2003 Jun; 10(6):481-90. PubMed ID: 12768194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
    Hu G; Guo D; Key NS; Conti-Fine BM
    Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta.
    Karpus WJ; Swanborg RH
    J Immunol; 1991 Feb; 146(4):1163-8. PubMed ID: 1671402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+ T cells.
    Ylikoski E; Lund R; Kyläniemi M; Filén S; Kilpeläinen M; Savolainen J; Lahesmaa R
    Eur J Immunol; 2005 Nov; 35(11):3297-306. PubMed ID: 16220539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL; Lin JT; Gorham JD
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes.
    Fargeas C; Wu CY; Nakajima T; Cox D; Nutman T; Delespesse G
    Eur J Immunol; 1992 Aug; 22(8):2173-6. PubMed ID: 1386318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.
    Kemper C; Chan AC; Green JM; Brett KA; Murphy KM; Atkinson JP
    Nature; 2003 Jan; 421(6921):388-92. PubMed ID: 12540904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of PPD-specific IFN-gamma-producing CD4+ T cells in the blood predicts the in vivo response to PPD.
    Martins MV; Lima MC; Duppre NC; Matos HJ; Spencer JS; Brennan PJ; Sarno EN; Fonseca L; Pereira GM; Pessolani MC
    Tuberculosis (Edinb); 2007 May; 87(3):202-11. PubMed ID: 17049309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of tolerance induced by TGF beta-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF beta.
    Alard P; Clark SL; Kosiewicz MM
    Eur J Immunol; 2004 Apr; 34(4):1021-30. PubMed ID: 15048712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.